- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.05. | GENinCode Plc: CARDIO inCode-Score Presentation at the European Society of Cardiology | 227 | ACCESSWIRE | Preventive Cardiology Congress Athens 2024OXFORD, ENGLAND / ACCESSWIRE / May 1, 2024 / GENinCode Plc, the polygenics company focused on the prevention of cardiovascular disease and ovarian cancer, gave... ► Artikel lesen | |
| 01.05. | GENinCode PLC - CARDIO inCode-Score presentation | 1 | RNS | ||
| 26.04. | GENinCode PLC - Grant of Options & Surrender of Existing Options | - | RNS | ||
| 05.04. | GENinCode Plc: CARDIO inCode-Score Clinical Publication on Polygenic Risk of Coronary Heart Disease | 978 | ACCESSWIRE | US Study Publication in the American Journal of Preventive CardiologyOXFORD, UK / ACCESSWIRE / April 5, 2024 / GENinCode Plc (www.genincode.com) the polygenics company focused on the prevention of cardiovascular... ► Artikel lesen | |
| 04.04. | GENinCode PLC - CARDIO inCode-Score® US study publication | 1 | RNS | ||
| 21.03. | GENinCode says ROCA recommended as ovarian cancer risk test in England | 1 | Alliance News | ||
| 21.03. | GENinCode PLC - New NICE Guidance for Ovarian Cancer | - | RNS | ||
| 09.02. | GENinCode PLC - Holding(s) in Company | - | RNS | ||
| 15.01. | GENinCode PLC - Holding(s) in Company | - | RNS | ||
| 11.01. | GENinCode PLC - Holding(s) in Company | - | RNS | ||
| 09.01. | GENinCode PLC - Result of GM and Total Voting Rights | - | RNS | ||
| 28.12.23 | IN BRIEF: GENinCode gets GBP57,000 in retail offer, well below maximum | 1 | Alliance News | ||
| 28.12.23 | GENinCode PLC - Result of Retail Offer | - | RNS | ||
| 21.12.23 | IN BRIEF: GENinCode raises GBP4 million via placing and subscription | 1 | Alliance News | ||
| 21.12.23 | GENinCode PLC - Result of Placing and Subscription | - | RNS | ||
| 21.12.23 | GENinCode PLC - Retail Offer | - | RNS | ||
| 21.12.23 | GENinCode PLC - Placing and Subscription | - | RNS | ||
| 29.11.23 | GENinCode PLC - CARDIO inCode-Score 510(k) FDA submission update | - | RNS | ||
| 29.11.23 | GENinCode PLC - Change of Adviser | - | RNS | ||
| 12.09.23 | GENinCode Plc: CARDIO inCode Study Results Presented at ESC Annual Meeting | 531 | ACCESSWIRE | Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode as method to target treatmentOXFORD, UK / ACCESSWIRE / September 12, 2023 / GENinCode Plc (AIM - GENI), the... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 28,670 | +2,28 % | Fresenius: Schöner Aufwärtstrend! | Der RuMaS Express-Service und die RuMaS Trading-Tipps bieten für Anfänger, erfahrene Anleger und Vieltrader gleichermaßen ein breites und qualitativ ausgezeichnetes Angebot an Börsentipps. Für Börsenneulinge... ► Artikel lesen | |
| PROGYNY | 27,530 | -15,29 % | Pre-market Movers: Novavax, MacroGenics, AEye, Sensus Healthcare, Progyny | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.10 A.M. ET).In the Green Novavax, Inc. (NVAX) is up over 108% at $9.30.
AEye... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,58 | +0,19 % | Siemens Healthineers verlängert Bestellung von Vorständin Staudinger | DJ Siemens Healthineers verlängert Bestellung von Vorständin Staudinger
FRANKFURT (Dow Jones)--Elisabeth Staudinger soll bis Ende September 2029 den Vorstand der Siemens Healthineers angehören.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,400 | +4,18 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Aktie des Dialyseanbieters Fresenius Medical Care (FMC) auf "Underweight" mit einem Kursziel von 35,40 Euro belassen. US-Konkurrent Davita... ► Artikel lesen | |
| GERRESHEIMER | 100,40 | +1,26 % | BARCLAYS stuft GERRESHEIMER AG auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Gerresheimer mit einem Kursziel von 125 Euro auf "Overweight" belassen. Lagerbestandsabbau der Kunden bleibe... ► Artikel lesen | |
| RXSIGHT | 59,31 | -3,44 % | Why RxSight (RXST) Shares Are Falling | ||
| CARL ZEISS MEDITEC | 94,55 | +0,64 % | Carl Zeiss Meditec: Die Bilanz und das Ringen um die 200-Tage-Linie | Mitte März endete die umfassende Erholung der Carl Zeiss Meditec-Aktie, seit Mitte April ringt sie um die wichtige 200-Tage-Linie. Die morgen erwarteten Ergebnisse des abgelaufenen Quartals dürften... ► Artikel lesen | |
| UNITEDHEALTH | 476,00 | -0,01 % | Smart Money Is Betting Big In UNH Options | ||
| PROCEPT BIOROBOTICS | 62,65 | -0,56 % | Unveiling 4 Analyst Insights On PROCEPT BioRobotics | ||
| PRIVIA HEALTH GROUP | 17,970 | -0,33 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2024 Financial Results | Practice Collections +7.4% compared to 1Q'23Implemented Providers +17.3% compared to 1Q'23Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health... ► Artikel lesen | |
| ATRICURE | 22,300 | +1,36 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| ADAPTHEALTH | 9,670 | +5,22 % | AdaptHealth Corp. Announces First Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| TREACE MEDICAL CONCEPTS | 4,380 | -1,13 % | Pre-market Movers: Treace Medical Concepts, DoubleVerify, Neo-Concept International, ZoomInfo Technologies, Innodata | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.50 A.M. ET).In the Green Neo-Concept International Group Holdings Limited... ► Artikel lesen | |
| GOODRX | 6,600 | -4,76 % | GoodRx Reports First Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading destination for prescription savings in the U.S., has released... ► Artikel lesen | |
| LIFEMD | 9,320 | +0,22 % | Earnings call: LifeMD raises 2024 revenue guidance after solid Q1 |
GENINCODE PLC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,106 Euro und damit +6,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
